Comparative secretome analyses using a hollow fiber culture system with label-free quantitative proteomics indicates the influence of PARK7 on cell proliferation and migration/invasion in lung adenocarcinoma

Journal of Proteome Research

Volumn 11, Issue 11, 2012, Pages 5167-5185

  Chang, Ying Hua ^a   Lee, Shu Hui ^a   Chang, Hua Chien ^a   Tseng, Yau Lin ^b   Lai, Wu Wei ^b   Liao, Chen Chung ^c   Tsay, Yeou Guang ^c   Liao, Pao Chi ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

cancer metastasis; hollow fiber culture system; label free quantitative proteomics; PARK7

Indexed keywords

DJ 1 PROTEIN; PROTEOME; SECRETOME; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CANCER TISSUE; CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR SECRETION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HOLLOW FIBER CULTURE SYSTEM; HOLLOW FIBER REACTOR; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; LUNG ADENOCARCINOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; TUMOR CELL; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ONCOGENE PROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS;

EID: 84868314556     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300362g     Document Type: Article

References (95)

1. World Health Organization. the Top Ten Causes of Death; Fact Sheet No. 310; Geneva: Switzerland, 2008.
2. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010 CA Cancer J. Clin. 2010, 60 (5) 277-300
3. American Cancer Society. Cancer Facts & Figures 2009; American Cancer Society: Atlanta, GA, 2009.
4. Zhang, H. J.; Wang, H. Y.; Zhang, H. T.; Su, J. M.; Zhu, J.; Wang, H. B.; Zhou, W. Y.; Zhang, H.; Zhao, M. C.; Zhang, L.; Chen, X. F. Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition Mol. Cell. Biochem. 2011, 355 (1-2) 309-314
5. Leber, M. F.; Efferth, T. Molecular principles of cancer invasion and metastasis (review) Int. J. Oncol. 2009, 34 (4) 881-895
6. Tjalsma, H.; Bolhuis, A.; Jongbloed, J. D.; Bron, S.; van Dijl, J. M. Signal peptide-dependent protein transport in Bacillus subtilis: A genome-based survey of the secretome Microbiol. Mol. Biol. Rev 2000, 64, 515-547
7. Volmer, M. W.; Stuhler, K.; Zapatka, M.; Schoneck, A.; Klein-Scory, S.; Schmiegel, W.; Meyer, H. E.; Schwarte-Waldhoff, I. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer Proteomics 2005, 5, 2587-2601
8. Wang, C. L.; Wang, C. I.; Liao, P. C.; Chen, C. D.; Liang, Y.; Chuang, W. Y.; Tsai, Y. H.; Chen, H. C.; Chang, Y. S.; Yu, J. S.; Wu, C. C.; Yu, C. J. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome J. Proteome Res. 2009, 8 (10) 4428-4440
9. Jin, L.; Zhang, Y.; Li, H.; Yao, L.; Fu, D.; Yao, X.; Xu, L. X.; Hu, X.; Hu, G. Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis Cell Res. 2012, 22, 1356-1373
10. Blanco, M. A.; Leroy, G.; Khan, Z.; Aleçković, M.; Zee, B. M.; Garcia, B. A.; Kang, Y. Global secretome analysis identifies novel mediators of bone metastasis Cell Res. 2012, 22, 1339-1355
11. Karagiannis, G. S.; Petraki, C.; Prassas, I.; Saraon, P.; Musrap, N.; Dimitromanolakis, A.; Diamandis, E. P. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis Oncotarget 2012, 3 (3) 267-285
12. Chiu, K. H.; Chang, Y. H.; Wu, Y. S.; Lee, S. H.; Liao, P. C. Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling J. Proteome Res. 2011, 10 (3) 1110-1125
13. Xue, H.; Lü, B.; Zhang, J.; Wu, M.; Huang, Q.; Wu, Q.; Sheng, H.; Wu, D.; Hu, J.; Lai, M. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach J. Proteome Res. 2010, 9 (1) 545-555
14. Yang, Y.; Lim, S. K.; Choong, L. Y.; Lee, H.; Chen, Y.; Chong, P. K.; Ashktorab, H.; Wang, T. T.; Salto-Tellez, M.; Yeoh, K. G.; Lim, Y. P. Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins J. Proteome Res. 2010, 9 (9) 4767-4778
15. Park, J. E.; Tan, H. S.; Datta, A.; Lai, R. C.; Zhang, H.; Meng, W.; Lim, S. K.; Sze, S. K. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes Mol. Cell. Proteomics 2010, 9 (6) 1085-1099
16. Yang, Y.; Lim, S. K.; Choong, L. Y.; Lee, H.; Chen, Y.; Chong, P. K.; Ashktorab, H.; Wang, T. T.; Salto-Tellez, M.; Yeoh, K. G.; Lim, Y. P. Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins J. Proteome Res. 2010, 9 (9) 4767-4778
17. Cox, G.; Jones, J.; O'Byrne, K. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer Clin. Cancer Res. 2000, 6, 2349-2355
18. Thant, A. A.; Nawa, A.; Kikkawa, F.; Ichigotani, Y.; Zhang, Y.; Sein, T. T.; Amin, A. R.; Hamaguchi, M. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells Clin. Exp. Metastasis 2000, 18 (5) 423-428
19. Papetti, M.; Herman, I. M. Mechanisms of normal and tumor-derived angiogenesis Am. J. Physiol.: Cell Physiol. 2002, 282 (5) C947-970
20. Yang, J. C.; Haworth, L.; Sherry, R. M.; Hwu, P.; Schwartzentruber, D. J.; Topalian, S. L.; Steinberg, S. M.; Chen, H. X.; Rosenberg, S. A. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer N. Engl. J. Med. 2003, 349 (5) 427-434
21. Wu, H. Y.; Chang, Y. H.; Chang, Y. C.; Liao, P. C. Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry J. Proteome Res. 2009, 8 (1) 380-389
22. Chang, Y. H.; Wu, C. C.; Chang, K. P.; Yu, J. S.; Chang, Y. C.; Liao, P. C. Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma J. Proteome Res. 2009, 8 (12) 5465-5474
23. Wen, Y. T.; Chang, Y. C.; Lin, L. C.; Liao, P. C. Collection of in vivo-like liver cell secretome with alternative sample enrichment method using a hollow fiber bioreactor culture system combined with tangential flow filtration for secretomics analysis Anal. Chim. Acta 2011, 684 (1-2) 72-79
24. Yang, P. C.; Luh, K. T.; Wu, R.; Wu, C. W. Characterization of the mucin differentiation in human lung adenocarcinoma cell lines Am. J. Respir. Cell Mol. Biol. 1992, 7 (2) 161-171
25. Chiu, K. H.; Chang, Y. H.; Wu, Y. S.; Lee, S. H.; Liao, P. C. Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling J. Proteome Res. 2011, 10 (3) 1110-1125
26. Olsen, J. V.; de Godoy, L. M. F.; Li, G.; Macek, B.; Mortensen, P.; Pesch, R.; Makarov, A.; Lange, O.; Horning, S.; Mann, M. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap Mol. Cell. Proteomics 2005, 4, 2010-2021
27. Tsou, C. C.; Tsai, C. F.; Tsui, Y. H.; Sudhir, P. R.; Wang, Y. T.; Chen, Y. J.; Chen, J. Y.; Sung, T. Y.; Hsu, W. L. IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation Mol. Cell. Proteomics 2010, 9 (1) 131-144
28. Bendtsen, J. D.; Nielsen, H.; von Heijne, G.; Brunak, S. Improved prediction of signal peptides: SignalP 3.0 J. Mol. Biol. 2004, 340, 783-795
29. Nielsen, H.; Krogh, A. Prediction of signal peptides and signal anchors by a hidden Markov model Proc. Int. Conf. Intell. Syst. Mol. Biol. 1998, 6, 122-130
30. Petersen, T. N.; Brunak, S.; von Heijne, G.; Nielsen, H. SignalP 4.0: discriminating signal peptides from transmembrane regions Nat. Methods 2011, 8 (10) 785-786
31. Bendtsen, J. D.; Jensen, L. J.; Blom, N.; Von Heijne, G.; Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion Protein Eng., Des. Sel. 2004, 17, 349-356
32. Dyrløv Bendtsen, J.; Kiemer, L.; Fausbøll, A.; Brunak, S. Non-classical protein secretion in bacteria BMC Microbiol, 2005, 5, 58
33. Möller, S.; Croning, M. D.; Apweiler, R. Evaluation of methods for the prediction of membrane spanning regions Bioinformatics 2001, 17, 646-653
34. Keshava Prasad, T. S.; Goel, R.; Kandasamy, K.; Keerthikumar, S.; Kumar, S.; Mathivanan, S.; Telikicherla, D.; Raju, R.; Shafreen, B.; Venugopal, A.; Balakrishnan, L.; Marimuthu, A.; Banerjee, S.; Somanathan, D. S.; Sebastian, A.; Rani, S.; Ray, S.; Harrys Kishore, C. J.; Kanth, S.; Ahmed, M.; Kashyap, M. K.; Mohmood, R.; Ramachandra, Y. L.; Krishna, V.; Rahiman, B. A.; Mohan, S.; Ranganathan, P.; Ramabadran, S.; Chaerkady, R.; Pandey, A. Human Protein Reference Database-2009 update Nucleic Acids Res. 2009, 767-772
35. Muthusamy, B.; Hanumanthu, G.; Suresh, S.; Rekha, B.; Srinivas, D.; Karthick, L.; Vrushabendra, B. M.; Sharma, S.; Mishra, G.; Chatterjee, P.; Mangala, K. S.; Shivashankar, H. N.; Chandrika, K. N.; Deshpande, N.; Suresh, M.; Kannabiran, N.; Niranjan, V.; Nalli, A.; Prasad, T. S.; Arun, K. S.; Reddy, R.; Chandran, S.; Jadhav, T.; Julie, D.; Mahesh, M.; John, S. L.; Palvankar, K.; Sudhir, D.; Bala, P.; Rashmi, N. S.; Vishnupriya, G.; Dhar, K.; Reshma, S.; Chaerkady, R.; Gandhi, T. K.; Harsha, H. C.; Mohan, S. S.; Deshpande, K. S.; Sarker, M.; Pandey, A. Plasma Proteome Database as a resource for proteomics research Proteomics 2005, 5 (13) 3531-3536
36. Mathivanan, S.; Simpson, R. J. ExoCarta: A compendium of exosomal proteins and RNA Proteomics 2009, 9 (21) 4997-5000
37. Shi, G. Y.; Hau, J. S.; Wang, S. J.; Wu, I. S.; Chang, B. I.; Lin, M. T.; Chow, Y. H.; Chang, W. C.; Wing, L. Y.; Jen, C. J.; Wu, H. L. Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells J. Biol. Chem. 1992, 267, 19363-19368
38. Chambers, A. F.; MacDonald, I. C.; Schmidt, E. E.; Morris, V. L.; Groom, A. C. Clinical targets for anti-metastasis therapy Adv. Cancer Res. 2000, 79, 91-121
39. Simpson, R. J.; Lim, J. W.; Moritz, R. L.; Mathivanan, S. Exosomes: Proteomic insights and diagnostic potential Expert Rev. Proteomics 2009, 6, 267-283
40. Mathivanan, S.; Lim, J. W.; Tauro, B. J.; Ji, H.; Moritz, R. L.; Simpson, R. J. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature Mol. Cell. Proteomics 2010, 9, 197-208
41. Théry, C.; Amigorena, S.; Raposo, G.; Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 2006, Chapter 3, Unit 3.22.
42. Simpson, R. J.; Jensen, S. S.; Lim, J. W. Proteomic profiling of exosomes: current perspectives Proteomics 2008, 8 (19) 4083-4099
43. Speers, A. E.; Wu, C. C. Proteomics of integral membrane proteins-theory and application Chem. Rev. 2007, 107 (8) 3687-3714
44. Coux, G.; Elías, M, M,; Trumper, L. Ischaemia/reperfusion in rat renal cortex: Vesicle leakiness and Na+, K+-ATPase activity in membrane preparations Nephrol., Dial., Transplant. 2009, 24 (10) 3020-3024
45. Théry, C.; Ostrowski, M.; Segura, E. Membrane vesicles as conveyors of immune responses Nat. Rev. Immunol. 2009, 9 (8) 581-593
46. Mathivanan, S.; Simpson, R. J. ExoCarta: A compendium of exosomal proteins and RNA Proteomics 2009, 9 (21) 4997-5000
47. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing J. R. Stattist. Soc. B 1995, 57, 289-300
48. Sussan, T. E.; Pletcher, M. T.; Murakami, Y.; Reeves, R. H. Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression Mol. Cancer 2005, 4, 28
49. Vinodhkumar, R.; Song, Y. S.; Ravikumar, V.; Ramakrishnan, G.; Devaki, T. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549) Chem.-Biol. Interact. 2007, 165 (3) 220-229
50. Hunter, K. W.; Crawford, N. P.; Alsarraj, J. Mechanisms of metastasis. Breast Cancer Res. 2008, 10 (Suppl. 1), S2.
51. Majewski, A.; Sobczak, M.; Wasik, A.; Skowronek, K.; Rèdowicz, M. J. Myosin VI in PC12 cells plays important roles in cell migration and proliferation but not in catecholamine secretion J. Muscle Res. Cell Motil. 2011, 32, 291-302
52. Baldi, A.; Lombardi, D.; Russo, P.; Palescandolo, E.; De Luca, A.; Santini, D.; Baldi, F.; Rossiello, L.; Dell'Anna, M. L.; Mastrofrancesco, A.; Maresca, V.; Flori, E.; Natali, P. G.; Picardo, M.; Paggi, M. G. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress Clin. Cancer Res. 2005, 11 (9) 3175-3183
53. Batmunkh, E.; Tátrai, P.; Szabó, E.; Lódi, C.; Holczbauer, A.; Páska, C.; Kupcsulik, P.; Kiss, A.; Schaff, Z.; Kovalszky, I. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma Hum. Pathol. 2007, 38 (10) 1508-1515
54. Ohnishi, T.; Hiraga, S.; Izumoto, S.; Matsumura, H.; Kanemura, Y.; Arita, N.; Hayakawa, T. Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues Clin. Exp. Metastasis 1998, 16 (8) 729-741
55. Magdolen, U.; Schroeck, F.; Creutzburg, S.; Schmitt, M.; Magdolen, V. Non-muscle alpha-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1) Biol. Chem. 2004, 385 (9) 801-808
56. Barbolina, M. V.; Adley, B. P.; Kelly, D. L.; Fought, A. J.; Scholtens, D. M.; Shea, L. D.; Stack, M. S. Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma Lab. Invest. 2008, 88 (6) 602-614
57. Kao, Y. R.; Shih, J. Y.; Wen, W. C.; Ko, Y. P.; Chen, B. M.; Chan, Y. L.; Chu, Y. W.; Yang, P. C.; Wu, C. W.; Roffler, S. R. Tumor-associated antigen L6 and the invasion of human lung cancer cells Clin. Cancer Res. 2003, 9 (7) 2807-2816
58. Liu, Y. C.; Yen, H. Y.; Chen, C. Y.; Chen, C. H.; Cheng, P. F.; Juan, Y. H.; Chen, C. H.; Khoo, K. H.; Yu, C. J.; Yang, P. C.; Hsu, T. L.; Wong, C. H. Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (28) 11332-11337
59. Pan, S. H.; Chao, Y. C.; Hung, P. F.; Chen, H. Y.; Yang, S. C.; Chang, Y. L.; Wu, C. T.; Chang, C. C.; Wang, W. L.; Chan, W. K.; Wu, Y. Y.; Che, T. F.; Wang, L. K.; Lin, C. Y.; Lee, Y. C.; Kuo, M. L.; Lee, C. H.; Chen, J. J.; Hong, T. M.; Yang, P. C. The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1 J. Clin. Invest. 2011, 121 (8) 3189-3205
60. Ho, C. C.; Huang, P. H.; Huang, H. Y.; Chen, Y. H.; Yang, P. C.; Hsu, S. M. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation Am. J. Pathol. 2002, 161 (5) 1647-1656
61. Hollingshead, M. G.; Alley, M. C.; Camalier, R. F.; Abbott, B. J.; Mayo, J. G.; Malspeis, L.; Grever, M. R. In vivo cultivation of tumor cells in hollow fibers Life Sci. 1995, 57 (2) 131-141
62. Abbott, A. Cell culture: Biology's new dimension Nature 2003, 424 (6951) 870-872
63. Yang, C.; Robbins, P. D. The roles of tumor-derived exosomes in cancer pathogenesis Clin. Dev. Immunol. 2011, 2011 842849
64. Hood, J. L.; San, R. S.; Wickline, S. A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis Cancer Res. 2011, 71 (11) 3792-3801
65. Wysoczynski, M.; Ratajczak, M. Z. Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors Int. J. Cancer 2009, 125 (7) 1595-1603
66. Grange, C.; Tapparo, M.; Collino, F.; Vitillo, L.; Damasco, C.; Deregibus, M. C.; Tetta, C.; Bussolati, B.; Camussi, G. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche Cancer Res. 2011, 71 (15) 5346-5356
67. Lee, M.; Fridman, R.; Mobashery, S. Extracellular proteases as targets for treatment of cancer metastases Chem. Soc. Rev. 2004, 33, 401-409
68. Hood, J. D.; Cheresh, D. A. Role of integrins in cell invasion and migration Nat. Rev. Cancer 2002, 2 (2) 91-100
69. Besson, A.; Assoian, R. K.; Roberts, J. M. Regulation of the cytoskeleton: An oncogenic function for CDK inhibitors? Nat. Rev. Cancer 2004, 4 (12) 948-955
70. Jones, R. G.; Thompson, C. B. Tumor suppressors and cell metabolism: A recipe for cancer growth Genes Dev. 2009, 23 (5) 537-548
71. Gillies, R. J.; Robey, I.; Gatenby, R. A. Causes and consequences of increased glucose metabolism of cancers J. Nucl. Med. 2008, 49 (Suppl 2) 24S-42S
72. Gatenby, R. A.; Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4 (11) 891-899
73. Kim, J. W.; Dang, C. V. Cancer's molecular sweet tooth and the Warburg effect Cancer Res. 2006, 66 (18) 8927-8930
74. Chen, E. I.; Hewel, J.; Krueger, J. S.; Tiraby, C.; Weber, M. R.; Kralli, A.; Becker, K.; Yates, J. R., III; Felding-Habermann, B. Adaptation of energy metabolism in breast cancer brain metastases Cancer Res. 2007, 67 (4) 1472-1486
75. Cellular Respiration and Carcinogenesis; Apte, S. P.; Sarangarajan, R., Eds.; Humana Press: New York, 2009.
76. Härmä, V.; Virtanen, J.; Mäkelä, R.; Happonen, A.; Mpindi, J. P.; Knuuttila, M.; Kohonen, P.; Lötjönen, J.; Kallioniemi, O.; Nees, M. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses PLoS One 2010, 5 (5) 10431
77. Sun, T.; Jackson, S.; Haycock, J. W.; MacNeil, S. Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents J. Biotechnol. 2006, 122 (3) 372-381
78. Jermutus, L.; Ryabova, L. A.; Plückthun, A. Recent advances in producing and selecting functional proteins by using cell-free translation Curr. Opin. Biotechnol. 1998, 9 (5) 534-548
79. Patel, V. J.; Thalassinos, K.; Slade, S. E.; Connolly, J. B.; Crombie, A.; Murrell, J. C.; Scrivens, J. H. A comparison of labeling and label-free mass spectrometry-based proteomics approaches J. Proteome Res. 2009, 8 (7) 3752-3759
80. Bonifati, V.; Rizzu, P.; van Baren, M. J.; Schaap, O.; Breedveld, G. J.; Krieger, E.; Dekker, M. C.; Squitieri, F.; Ibanez, P.; Joosse, M.; van Dongen, J. W.; Vanacore, N.; van Swieten, J. C.; Brice, A.; Meco, G.; van Duijn, C. M.; Oostra, B. A.; Heutink, P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 2003, 299 (5604) 256-259
81. Xu, J.; Zhong, N.; Wang, H.; Elias, J. E.; Kim, C. Y.; Woldman, I.; Pifl, C.; Gygi, S. P.; Geula, C.; Yankner, B. A. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis Hum. Mol. Genet. 2005, 14, 1231-1241
82. Maita, C.; Tsuji, S.; Yabe, I.; Hamada, S.; Ogata, A.; Maita, H.; Iguchi-Ariga, S. M.; Sasaki, H.; Ariga, H. Secretion of DJ-1 into the serum of patients with Parkinson's disease Neurosci. Lett. 2008, 431 (1) 86-89
83. Liu, H.; Wang, M.; Li, M.; Wang, D.; Rao, Q.; Wang, Y.; Xu, Z.; Wang, J. Expression and role of DJ-1 in leukemia Biochem. Biophys. Res. Commun. 2008, 375 (3) 477-483
84. Vasseur, S.; Afzal, S.; Tardivel-Lacombe, J.; Park, D. S.; Iovanna, J. L.; Mak, T. W. DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (4) 1111-1116
85. Hinklem, D. A.; Mullett, S. J.; Gabris, B. E.; Hamilton, R. L. DJ-1 expression in glioblastomas shows positive correlation with p53 expression and negative correlation with epidermal growth factor receptor amplification Neuropathology 2011, 31 (1) 29-37
86. McNally, R. S.; Davis, B. K.; Clements, C. M.; Accavitti-Loper, M. A.; Mak, T. W.; Ting, J. P. DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB J. Biol. Chem. 2011, 286 (6) 4098-4106
87. He, X.; Zheng, Z.; Li, J.; Ben, Q.; Liu, J.; Zhang, J.; Ji, J.; Yu, B.; Chen, X.; Su, L.; Zhou, L.; Liu, B.; Yuan, Y. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA Carcinogenesis 2012, 33 (3) 555-562
88. Davidson, B.; Hadar, R.; Schlossberg, A.; Sternlicht, T.; Slipicevic, A.; Skrede, M.; Risberg, B.; Flørenes, V. A.; Kopolovic, J.; Reich, R. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma Hum Pathol 2008, 39 (1) 87-95
89. Kim, R. H.; Peters, M.; Jang, Y.; Shi, W.; Pintilie, M.; Fletcher, G. C.; DeLuca, C.; Liepa, J.; Zhou, L.; Snow, B.; Binari, R. C.; Manoukian, A. S.; Bray, M. R.; Liu, F. F.; Tsao, M. S.; Mak, T. W. DJ-1, a novel regulator of the tumor suppressor PTE Cancer Cell 2005, 7 (3) 263-273
90. Yuen, H. F.; Chan, Y. P.; Law, S.; Srivastava, G.; El-Tanani, M.; Mak, T. W.; Chan, K. W. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma Cancer Epidemiol., Biomarkers Prev, 2008, 17 (12) 3593-3602
91. Bai, J.; Guo, C.; Sun, W.; Li, M.; Meng, X.; Yu, Y.; Jin, Y.; Tong, D.; Geng, J.; Huang, Q.; Qi, J.; Fu, S. DJ-1 may contribute to metastasis of non-small cell lung cancer Mol, Biol, Rep, 2012, 39 (3) 2697-2703
92. Inberg, A.; Linial, M. Protection of pancreatic beta-cells from various stress conditions is mediated by DJ-1 J. Biol. Chem. 2010, 285 (33) 25686-25698
93. Zeng, H. Z.; Qu, Y. Q.; Zhang, W. J.; Xiu, B.; Deng, A. M.; Liang, A. B. Proteomic Analysis Identified DJ-1 as a cisplatin resistant marker in non-small cell lung cancer Int. J. Mol. Sci. 2011, 12 (6) 3489-3499
94. Chang, Y. J.; Chiu, C. C.; Wu, C. H.; An, J.; Wu, C. C.; Liu, T. Z.; Wei, P. L.; Huang, M. T. Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma Ann. Surg. Oncol. 2010, 17 (6) 1703-1709
95. Dong, D.; Ni, M.; Li, J.; Xiong, S.; Ye, W.; Virrey, J. J.; Mao, C.; Ye, R.; Wang, M.; Pen, L.; Dubeau, L.; Groshen, S.; Hofman, F. M.; Lee, A. S. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development Cancer Res. 2008, 68 (2) 498-505